UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049841
Receipt number R000056775
Scientific Title Clinical Effects of Delgocitinib Ointment on Skin Barrier Dysfunction in Pediatric Atopic Dermatitis
Date of disclosure of the study information 2022/12/22
Last modified on 2024/01/03 18:55:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Effects of Delgocitinib Ointment on Skin Barrier Dysfunction in Pediatric Atopic Dermatitis

Acronym

Clinical Effects of Delgocitinib Ointment on Skin Barrier Dysfunction in Pediatric Atopic Dermatitis

Scientific Title

Clinical Effects of Delgocitinib Ointment on Skin Barrier Dysfunction in Pediatric Atopic Dermatitis

Scientific Title:Acronym

Clinical Effects of Delgocitinib Ointment on Skin Barrier Dysfunction in Pediatric Atopic Dermatitis

Region

Japan


Condition

Condition

Atopic Dermatitis

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical efficacy of topical delgocitinib on skin barrier dysfunction in atopic dermatitis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in TEWL and SCH from baseline to 12 weeks

Key secondary outcomes

Change in TARC, SCCA2, EASI, pEASI and vIGA from baseline to 12 weeks
TEWL, SCH, and questionnaire scores for eczematous and non-eczematous areas at 12 weeks
TARC, SCCA2, EASI, pEASI and vIGA at 12 weeks
EIS results at baseline and at 12 weeks, and findings from tape stripping


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Corectim group
Colectim ointment twice a day, but Lidomex ointment can be used in case of eczema exacerbation.

Interventions/Control_2

Steroid group
Lidomex ointment twice daily, if eczema improves, patients may be switched to Proactive therapy. Protopic ointment may be used on the head and neck area.

Interventions/Control_3

Non-AD group
No treatment

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 months-old <=

Age-upper limit

12 years-old >=

Gender

Male and Female

Key inclusion criteria

Pediatric patients with atopic dermatitis who have eczema on the elbow fossa with vIGA-AD score of 2 or higher

Key exclusion criteria

(1) Patients with a history of use of group II or higher topical steroids or delgocitinib ointment on the forearm within 1 month
(2) Patients with signs of infection on the forearm
(3) Patients with a history of use of biological drugs within 1 year or who are going to use biological drugs during participation in the study
(4) Other patients deemed inappropriate as research subjects by the principal investigator

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Sakura
Middle name
Last name Sato

Organization

National Hospital Organization Sagamihara National Hospital

Division name

Clinical Research Center for Allergy and Rheumatology

Zip code

252-0392

Address

18-1 Sakuradai, Minamiku, Sagamihara, Kanagawa

TEL

042-742-8311

Email

ssakura8010@foodallergy.jp


Public contact

Name of contact person

1st name Akira
Middle name
Last name Kawai

Organization

National Hospital Organization Sagamihara National Hospital

Division name

Department of pediatrics

Zip code

252-0392

Address

18-1 Sakuradai, Minamiku, Sagamihara, Kanagawa

TEL

042-742-8311

Homepage URL


Email

akawai-ykh@umin.ac.jp


Sponsor or person

Institute

National Hospital Organization Sagamihara National Hospital

Institute

Department

Personal name



Funding Source

Organization

Torii Pharmaceutical Co.,Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sagamihara Hospital Ethics Committee of the National Hospital Organization

Address

18-1 Sakuradai, Minamiku, Sagamihara, Kanagawa

Tel

042-742-8311

Email

makino.megumi.bn@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 10 Month 01 Day

Date of IRB

2022 Year 12 Month 13 Day

Anticipated trial start date

2022 Year 12 Month 22 Day

Last follow-up date

2024 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 20 Day

Last modified on

2024 Year 01 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056775


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name